Leukemia, Acute Lymphoblastic, Adult Clinical Trials

• Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002531 - Active, not recruiting
  non-T, non-B adult acute lymphoblastic leukemia; untreated adult acute lymphoblastic leukemia; B-cell adult acute lymphoblastic leukemia; ...
  
• Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00003700 - Active, not recruiting
  L1 adult acute lymphoblastic leukemia; L2 adult acute lymphoblastic leukemia; untreated adult acute lymphoblastic leukemia
  
• 506U78 in Treating Patients With Recurrent or Refractory Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00006020 - Active, not recruiting
  recurrent adult acute lymphoblastic leukemia; L1 adult acute lymphoblastic leukemia; L2 adult acute lymphoblastic leukemia; ...
  
• Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00061945 - Active, not recruiting
  B-cell adult acute lymphoblastic leukemia; L1 adult acute lymphoblastic leukemia; L2 adult acute lymphoblastic leukemia; ...
  
• Monoclonal Antibody Therapy, Cyclophosphamide, and Total-Body Irradiation Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Recurrent Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003870 - Active, not recruiting
  adult acute lymphoblastic leukemia in remission; recurrent adult acute lymphoblastic leukemia; recurrent childhood acute lymphoblastic leukemia; ...
  
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00109837 - Recruiting
  L1 adult acute lymphoblastic leukemia; L2 adult acute lymphoblastic leukemia; untreated adult acute lymphoblastic leukemia
  
• Bone Marrow Transplantation in Treating Patients With Acute Leukemia in First or Second Remission
  ClinicalTrials.gov Identifier: NCT00002534 - Active, not recruiting
  childhood acute myeloid leukemia in remission; adult acute lymphoblastic leukemia in remission; recurrent adult acute myeloid leukemia; ...
  
• Sorafenib in Treating Patients With Relapsed or Refractory Leukemia
  ClinicalTrials.gov Identifier: NCT00131989 - Active, not recruiting
  adult acute erythroid leukemia; adult acute lymphoblastic leukemia; adult acute monoblastic and acute monocytic leukemia; ...
  
• Filgrastim-Treated Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Leukemia
  ClinicalTrials.gov Identifier: NCT00025545 - Active, not recruiting
  adult acute lymphoblastic leukemia in remission; recurrent adult acute myeloid leukemia; acute undifferentiated leukemia; ...
  
• Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00048958 - Recruiting
  adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute lymphoblastic leukemia; ...
  
• Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00005802 - Active, not recruiting
  adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute lymphoblastic leukemia; childhood acute myeloid leukemia
  
• Combination Chemotherapy Followed By Filgrastim or Sargramostim in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00053131 - Active, not recruiting
  recurrent adult acute myeloid leukemia; recurrent childhood acute myeloid leukemia; recurrent adult acute lymphoblastic leukemia; ...
  
• Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Interleukin-2 in Treating Patients With Acute Leukemia
  ClinicalTrials.gov Identifier: NCT00008190 - Active, not recruiting
  adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute lymphoblastic leukemia; childhood acute myeloid leukemia; ...
  
• Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia
  ClinicalTrials.gov Identifier: NCT00040690 - Active, not recruiting
  L3 adult acute lymphoblastic leukemia; adult Burkitt's lymphoma; untreated adult acute lymphoblastic leukemia
  
• Dexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00075725 - Recruiting
  untreated childhood acute lymphoblastic leukemia; B-cell childhood acute lymphoblastic leukemia; untreated adult acute lymphoblastic leukemia; ...
  
• Flavopiridol in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00101231 - Recruiting
  adult acute erythroid leukemia; adult acute lymphoblastic leukemia; adult acute monoblastic and acute monocytic leukemia; ...
  
• Combination Chemotherapy in Treating Children With Very High Risk Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003783 - Active, not recruiting
  L2 childhood acute lymphoblastic leukemia; untreated childhood acute lymphoblastic leukemia; L1 childhood acute lymphoblastic leukemia; ...
  
• Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00006008 - Completed
  L3 adult acute lymphoblastic leukemia; L1 adult acute lymphoblastic leukemia; recurrent adult acute lymphoblastic leukemia; ...
  
• Radiation Therapy to the Head or Intrathecal Chemotherapy Plus High Dose Cytarabine in Preventing CNS Disease in Children With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00019409 - Active, not recruiting
  L2 childhood acute lymphoblastic leukemia; untreated childhood acute lymphoblastic leukemia; L1 childhood acute lymphoblastic leukemia; ...
  
• Comparison of Different Combination Chemotherapy Regimens in Treating Children With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00005945 - Active, not recruiting
  untreated childhood acute lymphoblastic leukemia; L1 childhood acute lymphoblastic leukemia; L2 childhood acute lymphoblastic leukemia; ...
  
• Vaccine Therapy in Treating Patients With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00020670 - Active, not recruiting
  recurrent childhood acute lymphoblastic leukemia; recurrent adult acute lymphoblastic leukemia; B-cell childhood acute lymphoblastic leukemia; ...
  
• Cellular Adoptive Immunotherapy in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndromes That Relapsed After Donor Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00107354 - Active, not recruiting
  adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute lymphoblastic leukemia; ...
  
• Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00002700 - Active, not recruiting
  untreated adult acute lymphoblastic leukemia; stage I adult lymphoblastic lymphoma; stage III adult lymphoblastic lymphoma; ...
  
• Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002532 - Active, not recruiting
  recurrent adult acute lymphoblastic leukemia
  
• Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt''s or Burkitt''s-Like Lymphoma or Leukemia
  ClinicalTrials.gov Identifier: NCT00133991 - Recruiting
  L3 adult acute lymphoblastic leukemia; adult Burkitt''s lymphoma; untreated adult acute lymphoblastic leukemia
  
• Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia
  ClinicalTrials.gov Identifier: NCT00039130 - Recruiting
  L3 adult acute lymphoblastic leukemia; adult Burkitt's lymphoma; untreated adult acute lymphoblastic leukemia
  
• Randomized Controlled Trial to Test Efficacy of High-Dose MTX for Adult Acute Lymphoblastic Leukemia (ALL)
  ClinicalTrials.gov Identifier: NCT00131027 - Recruiting
  Acute Lymphoblastic Leukemia
  
• Combination Chemotherapy and Radiation Therapy in Treating Children With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00004034 - Active, not recruiting
  L2 childhood acute lymphoblastic leukemia; untreated childhood acute lymphoblastic leukemia; cardiac toxicity; ...
  
• Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma
  ClinicalTrials.gov Identifier: NCT00002766 - Active, not recruiting
  Philadelphia chromosome positive chronic myelogenous leukemia; adult acute lymphoblastic leukemia; adult lymphoblastic lymphoma; ...
  
• Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00003960 - Active, not recruiting
  untreated adult acute myeloid leukemia; chronic phase chronic myelogenous leukemia; Previously Treated Myelodysplastic Syndrome; ...
  
• Chemotherapy With or Without Total-Body Irradiation Prior to Bone Marrow Transplantation in Treating Children With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00002961 - Active, not recruiting
  recurrent childhood acute lymphoblastic leukemia; childhood acute lymphoblastic leukemia in remission
  
• Phase 2 Study of Applying Pediatric Regimens to Younger Adult Patients with Acute Lymphoblastic Leukemia (ALL)
  ClinicalTrials.gov Identifier: NCT00131053 - Recruiting
  Acute Lymphoblastic Leukemia
  
• Diagnostic Study of Patients With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00003861 - Recruiting
  untreated adult acute lymphoblastic leukemia
  
• VNP40101M and Cytarabine in Treating Patients With Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00070538 - Active, not recruiting
  adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
  
• Combination Chemotherapy in Treating Children With Relapsed or Refractory Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003729 - Active, not recruiting
  L2 childhood acute lymphoblastic leukemia; L1 childhood acute lymphoblastic leukemia; recurrent childhood acute lymphoblastic leukemia
  
• Biological Therapy in Treating Patients With Advanced Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00052520 - Recruiting
  adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute lymphoblastic leukemia; ...
  
• Phase II/III Randomized Study of Transplantation With Unmodified Versus T-Cell Depleted, Unrelated Allogeneic Bone Marrow in Patients With Leukemia
  ClinicalTrials.gov Identifier: NCT00006451 - Active, not recruiting
  acute undifferentiated leukemia; accelerated phase chronic myelogenous leukemia; Graft Versus Host Disease; ...
  
• Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00016302 - Active, not recruiting
  untreated childhood acute lymphoblastic leukemia; T-cell childhood acute lymphoblastic leukemia
  
• Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00005603 - Active, not recruiting
  childhood acute lymphoblastic leukemia in remission; B-cell childhood acute lymphoblastic leukemia
  
• Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00005585 - Active, not recruiting
  childhood acute lymphoblastic leukemia in remission; B-cell childhood acute lymphoblastic leukemia
  
• 3-AP and High-Dose Cytarabine in Treating Patients With Advanced Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00077181 - Active, not recruiting
  adult acute lymphoblastic leukemia; adult acute myeloid leukemia; Chronic Myelogenous Leukemia; secondary acute myeloid leukemia
  
• Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00002719 - Active, not recruiting
  adult acute myelomonocytic leukemia (M4); untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
  
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Acute Lymphoblastic Leukemia That Has Relapsed in the CNS or Testes
  ClinicalTrials.gov Identifier: NCT00096135 - Recruiting
  recurrent childhood acute lymphoblastic leukemia; B-cell childhood acute lymphoblastic leukemia; T-cell childhood acute lymphoblastic leukemia; ...
  
• Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Acute Myeloid Leukemia in Second Remission
  ClinicalTrials.gov Identifier: NCT00002768 - Active, not recruiting
  adult acute differentiated monocytic leukemia (M5b); adult acute myeloblastic leukemia without maturation (M1); ...
  
• Temozolomide and VNP40101M in Treating Patients With Relapsed or Refractory Leukemias
  ClinicalTrials.gov Identifier: NCT00098436 - Active, not recruiting
  adult acute lymphoblastic leukemia; adult acute myeloid leukemia; blastic phase chronic myelogenous leukemia; relapsing chronic myelogenous leukemia; ...
  
• Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00031655 - Active, not recruiting
  adult acute lymphoblastic leukemia in remission; childhood acute lymphoblastic leukemia in remission
  
• Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002549 - Active, not recruiting
  adult acute myelomonocytic leukemia (M4); untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
  
• Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00087204 - Completed
  adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
  
• Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00006122 - Active, not recruiting
  untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
  
• Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00006045 - Active, not recruiting
  adult acute differentiated monocytic leukemia (M5b); adult acute myeloblastic leukemia without maturation (M1); ...
  
• Feasibility of Risk-Adapted Therapy in Young Adult Acute Lymphoblastic Leukemia: a Multicenter Trial
  ClinicalTrials.gov Identifier: NCT00222027 - Active, not recruiting
  Acute Lymphoblastic Leukemia
  
• 506U78 in Treating Patients With Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma
  ClinicalTrials.gov Identifier: NCT00003837 - Completed
  recurrent adult acute lymphoblastic leukemia; T-cell adult acute lymphoblastic leukemia; recurrent adult lymphoblastic lymphoma
  
• Description and Prognostic Evaluation of Four Biological Parameters of Blast Cells in Adult Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00188084 - Recruiting
  Adult Acute Lymphoblastic Leukemia
  
• Therapy for Newly Diagnosed Patients with Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00137111 - Active, not recruiting
  Acute Lymphoblastic Leukemia
  
• Monoclonal Antibody in Treating Patients With Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00006084 - Active, not recruiting
  adult acute differentiated monocytic leukemia (M5b); adult acute myeloblastic leukemia without maturation (M1); ...
  
• Total-Body Irradiation Plus Stem Cell Transplantation And White Blood Cell Infusion in Treating Older Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00005801 - Active, not recruiting
  adult acute differentiated monocytic leukemia (M5b); adult acute myeloblastic leukemia without maturation (M1); ...
  
• Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00103285 - Recruiting
  untreated childhood acute lymphoblastic leukemia; B-cell childhood acute lymphoblastic leukemia
  
• Combination Chemotherapy With or Without Donor Bone Marrow Transplantation in Treating Infants With Previously Untreated Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00022126 - Active, not recruiting
  untreated childhood acute lymphoblastic leukemia; L1 childhood acute lymphoblastic leukemia; L2 childhood acute lymphoblastic leukemia; ...
  
• Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00262925 - Recruiting
  Recurrent Adult Acute Lymphoblastic Leukemia
  
• Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00004862 - Completed
  recurrent adult acute myeloid leukemia; recurrent adult acute lymphoblastic leukemia
  
• FR901228 in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00024180 - Completed
  Waldenstrom's Macroglobulinemia; recurrent adult acute myeloid leukemia; recurrent adult acute lymphoblastic leukemia; ...
  
• Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00002925 - Active, not recruiting
  untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
  
• PSC 833, Daunorubicin, and Cytarabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00004217 - Active, not recruiting
  untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
  
• Combination Chemotherapy Plus PSC 833 Followed by Interleukin-2 in Treating Older Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00003190 - Active, not recruiting
  untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
  
• 506U78 in Treating Patients With Refractory Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00002970 - Active, not recruiting
  recurrent childhood lymphoblastic lymphoma; T-cell childhood acute lymphoblastic leukemia; recurrent childhood acute lymphoblastic leukemia
  
• 17-N-Allylamino-17-Demethoxygeldanamycin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, or Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00098423 - Recruiting
  Acute Lymphocytic Leukemia; Acute Myeloid Leukemia; adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; ...
  
• 506U78 in Treating Patients With Refractory or Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
  ClinicalTrials.gov Identifier: NCT00003545 - Completed
  recurrent adult lymphoblastic lymphoma; recurrent adult T-cell leukemia/lymphoma; recurrent childhood lymphoblastic lymphoma; ...
  
• Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00004215 - Active, not recruiting
  Anemia; adult acute poorly differentiated monocytic leukemia (M5a); adult acute myeloblastic leukemia with maturation (M2); ...
  
• Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplantation for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00093587 - Active, not recruiting
  adult acute lymphoblastic leukemia; adult acute myeloid leukemia; Graft Versus Host Disease; secondary acute myeloid leukemia
  
• Idarubicin, Cytarabine, and Tipifarnib in Treating Patients With Newly Diagnosed Myelodysplastic Syndromes or Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00096122 - Active, not recruiting
  adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; ...
  
• CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase
  ClinicalTrials.gov Identifier: NCT00084916 - Completed
  adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
  
• Hormone Therapy Plus Chemotherapy in Treating Children With Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00003437 - Active, not recruiting
  recurrent childhood acute lymphoblastic leukemia; untreated childhood acute lymphoblastic leukemia
  
• Tipifarnib and Etoposide in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00112853 - Active, not recruiting
  adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia
  
• STI 571 (GLIVEC) in the Treatment of Adult Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00376467 - Recruiting
  Acute Lymphoblastic Leukemia
  
• OTI-010 for Graft-Versus-Host Disease Prophylaxis in Treating Patients Who Are Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies
  ClinicalTrials.gov Identifier: NCT00081055 - Active, not recruiting
  adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute myeloid leukemia and other myeloid malignancies; ...
  
• Hyper-CVAD Plus Dasatinib in Philadelphia/BCR-ABL Positive ALL
  ClinicalTrials.gov Identifier: NCT00390793 - Recruiting
  Leukemia, Lymphocytic, Acute; Lymphoblastic Leukemia, Acute, Adult; Leukemia, Lymphoblastic, Acute, Philadelphia-Positive
  
• Cyclosporine, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00066794 - Active, not recruiting
  adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia
  
• Tipifarnib in Treating Older Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00093418 - Active, not recruiting
  adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia
  
• High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00002945 - Active, not recruiting
  adult acute myelomonocytic leukemia (M4); untreated adult acute myeloid leukemia; adult acute monocytic leukemia (M5); ...
  
• An Extension Study of the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Patients With Ph + Leukemia
  ClinicalTrials.gov Identifier: NCT00171223 - Active, not recruiting
  Philadelphia Positive Chronic Myeloid Leukemia in Accelerated Phase, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
  
• An Extension Study of the Safety and Anti-Leukemic Effects of Imatinib Mesylate in Adult Patients With Ph + Leukemia
  ClinicalTrials.gov Identifier: NCT00171249 - Active, not recruiting
  Philadelphia Positive Chronic Myeloid Leukemia in Accelerated Phase, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
  
• Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00005596 - Active, not recruiting
  untreated childhood acute lymphoblastic leukemia
  
• Study of mAb 216 With Chemotherapy for Treatment of Pediatric Relapsed or Refractory B-Progenitor Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00313053 - Recruiting
  Lymphocytic Leukemia, B Cell, Acute; Leukemia, B-Cell; Leukemia, Lymphocytic, Acute; Lymphoblastic Leukemia, Acute, Childhood; Leukemia, Lymphocytic, Acute, L1
  
• Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab
  ClinicalTrials.gov Identifier: NCT00199004 - Recruiting
  Adult Acute Lymphocytic Leukemia
  
• Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00006462 - Active, not recruiting
  recurrent childhood acute lymphoblastic leukemia; recurrent childhood acute myeloid leukemia
  
• Cytarabine and Daunorubicin with Or Without Gemtuzumab Ozogamicin in Treating Older Patients with Acute Myeloid Leukemia Or Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00121303 - Active, not recruiting
  adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; ...
  
• Combination Chemotherapy and Imatinib Mesylate in Treating Children With Relapsed Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00049569 - Completed
  recurrent childhood acute lymphoblastic leukemia; non-T, non-B childhood acute lymphoblastic leukemia; T-cell childhood acute lymphoblastic leukemia; ...
  
• Molecular Epidemiology of Childhood Leukemia in Northern and Central California
  ClinicalTrials.gov Identifier: NCT00015587 - Recruiting
  Leukemia; Acute Myelocytic Leukemia; Acute Lymphoblastic Leukemia; Acute Myelogenous Leukemia
  
• Combination Chemotherapy in Treating Children With Acute Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00002812 - Completed
  L2 childhood acute lymphoblastic leukemia; untreated childhood acute lymphoblastic leukemia; L1 childhood acute lymphoblastic leukemia
  
• Rituximab Plus Interleukin-2 in Treating Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00010192 - Active, not recruiting
  adult acute lymphoblastic leukemia; adult non-Hodgkin's lymphoma
  
• Eculizumab in Treating Patients With Paroxysmal Nocturnal Hemoglobinuria
  ClinicalTrials.gov Identifier: NCT00112983 - Completed
  adult acute lymphoblastic leukemia; adult acute myeloid leukemia
  
• Monoclonal Antibody (mAb) 216 With Chemotherapy in Adult Relapsed or Refractory B-Lineage Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00313079 - Recruiting
  Leukemia; Leukemia, Lymphocytic; Leukemia, B-Cell; Leukemia, B-Cell, Acute
  
• Treatment of Relapsed T-Cell Acute Lymphoblastic Leukemia or T-Lymphoblastic Lymphoma With MabCampath
  ClinicalTrials.gov Identifier: NCT00199030 - Recruiting
  Adult Acute Lymphocytic Leukemia T-Cell; Lymphoma, Lymphoblastic
  
• Bryostatin 1 and Cytarabine in Treating Patients With Relapsed Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00017342 - Active, not recruiting
  recurrent adult acute myeloid leukemia; adult acute myeloid leukemia with t(8;21)(q22;q22); adult acute myeloid leukemia with t(16;16)(p13;q22); ...
  
• Fludarabine and Total-Body Irradiation Followed By Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate
  ClinicalTrials.gov Identifier: NCT00036738 - Recruiting
  recurrent childhood acute lymphoblastic leukemia; recurrent adult acute lymphoblastic leukemia; blastic phase chronic myelogenous leukemia; ...
  
• Combination Chemotherapy Plus Biological Therapy in Treating Patients With Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00003405 - Active, not recruiting
  untreated adult acute myeloid leukemia; childhood acute megakaryocytic leukemia (M7); adult acute differentiated monocytic leukemia (M5b); ...
  
• Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation
  ClinicalTrials.gov Identifier: NCT00002456 - Completed
  recurrent adult non-Hodgkin's lymphoma; recurrent childhood acute lymphoblastic leukemia; recurrent adult acute myeloid leukemia; ...
  
• Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00002816 - Active, not recruiting
  Quality of Life; recurrent childhood acute lymphoblastic leukemia
  
• Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00091234 - Active, not recruiting
  adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia
  
• Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00027872 - Active, not recruiting
  adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia